ETOVIVEX Trademark

Trademark Overview

On Friday, March 2, 2007, a trademark application was filed for ETOVIVEX with the United States Patent and Trademark Office. The USPTO has given the ETOVIVEX trademark a serial number of 79036944. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 2, 2017. This trademark is owned by BAYER SCHERING PHARMA AG. The ETOVIVEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases in the fields of oncology, central nervous system and auto-immune diseases, parkinson, and multiple sclerosis; preparations containing hormones for medical purposes
etovivex

General Information

Serial Number79036944
Word MarkETOVIVEX
Filing DateFriday, March 2, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 2, 2017
Registration Number3376260
Registration DateTuesday, January 29, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases in the fields of oncology, central nervous system and auto-immune diseases, parkinson, and multiple sclerosis; preparations containing hormones for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Intellectual Property GmbH
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameBayer Pharma Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBAYER SCHERING PHARMA AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBAYER SCHERING PHARMA AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, September 21, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, September 21, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, August 21, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, July 31, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, July 31, 2015INVALIDATION PROCESSED
Tuesday, May 5, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 5, 2014CANCELLED SECTION 71
Friday, September 21, 2012CHANGE OF OWNER RECEIVED FROM IB
Friday, March 2, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 23, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, May 4, 2008FINAL DISPOSITION NOTICE SENT TO IB
Sunday, May 4, 2008FINAL DISPOSITION PROCESSED
Tuesday, April 29, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 29, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, November 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2007NOTICE OF PUBLICATION
Saturday, October 6, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 2, 2007ASSIGNED TO LIE
Saturday, September 1, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 28, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 28, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 28, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 13, 2007REFUSAL PROCESSED BY IB
Wednesday, June 27, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 27, 2007REFUSAL PROCESSED BY MPU
Friday, June 22, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 21, 2007NON-FINAL ACTION WRITTEN
Friday, June 15, 2007ASSIGNED TO EXAMINER
Friday, May 18, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, May 17, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

etovivex diseases preparations multiple sclerosis parkinson containing medical purposes immune hormones